Skip to main content
. 2023 Jan 3;18:100534. doi: 10.1016/j.mtbio.2022.100534

Fig. 3.

Fig. 3

In vitro antibacterial capacity in bacterial infection model. (A) Fluorescence images of HaCaT cells infected by MuRSA for 4 ​h, followed by treating with different preparations for 12 ​h. Live and dead cells were respectively stained with calcein-AM (green fluorescence) and dead cells were stained with PI (red fluorescence). (B) Representative TEM images of MuRSA-infected HaCaT cells (MOI ​= ​20) after being treated with different preparations for 12 ​h. (C) The ratio of PI-positive cells to total cells in (A). (D) Survival rate of intracellular MuRSA cells after being treated with different preparations for 12 ​h (n ​= ​3). (E) Rate of MuRSA adhesion to HaCaT after exposure to different preparations for 12 ​h (n ​= ​3). Data are presented as the mean ​± ​SD: ∗p ​< ​0.05, ∗∗p ​< ​0.01, ∗∗∗p ​< ​0.001.